Clinical Trials
-
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
Black people and Native Americans are under-represented in Cancer Drug trials of new drugs
Black people and Native Americans are under-represented in clinical trials of new drugs, even when the treatment is aimed at…
Read More »
